Literature DB >> 16600664

Leucine-rich repeat kinase 2: relevance to Parkinson's disease.

Luxuan Guo1, Wen Wang, Shu G Chen.   

Abstract

Human leucine-rich repeat kinase 2 (LRRK2) is a novel kinase belonging to the ROCO protein superfamily (Ras of complex proteins (Roc) with a C-terminal of Roc domain). This large complex protein of 280kDa contains several functional domains including leucine-rich repeats, Ras-related GTPase, mitogen-activated protein kinase kinase kinase (MAPKKK), and WD40 repeats. While definitive functions of LRRK2 have yet to be described, the domain structure of LRRK2 suggests that it plays an important role in the regulation of signal transduction cascades through its dual enzymatic activities of GTPase and MAPKKK. Moreover, mutations in LRRK2 have been found to be thus far the most frequent cause of late-onset familial and idiopathic Parkinson's disease. Further investigations should allow for the elucidation of how pathogenic mutations trigger changes in the structure and function of LRRK2 that lead to aberrant signal transduction and neurodegeneration in Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16600664     DOI: 10.1016/j.biocel.2006.02.009

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  15 in total

1.  LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease.

Authors:  Chen Yao; Rabih El Khoury; Wen Wang; Tara A Byrd; Elizabeth A Pehek; Colin Thacker; Xiongwei Zhu; Mark A Smith; Amy L Wilson-Delfosse; Shu G Chen
Journal:  Neurobiol Dis       Date:  2010-04-09       Impact factor: 5.996

2.  LRRK2 G2019S mutation: frequency and haplotype data in South African Parkinson's disease patients.

Authors:  Soraya Bardien; Angelica Marsberg; Rowena Keyser; Debbie Lombard; Suzanne Lesage; Alexis Brice; Jonathan Carr
Journal:  J Neural Transm (Vienna)       Date:  2010-06-11       Impact factor: 3.575

3.  Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease.

Authors:  Michael H Yan; Xinglong Wang; Xiongwei Zhu
Journal:  Free Radic Biol Med       Date:  2012-11-29       Impact factor: 7.376

4.  Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 rats.

Authors:  Jang-Won Lee; Victor Tapias; Roberto Di Maio; J Timothy Greenamyre; Jason R Cannon
Journal:  Neurobiol Aging       Date:  2014-07-15       Impact factor: 4.673

5.  The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity.

Authors:  Luxuan Guo; Payal N Gandhi; Wen Wang; Robert B Petersen; Amy L Wilson-Delfosse; Shu G Chen
Journal:  Exp Cell Res       Date:  2007-07-19       Impact factor: 3.905

Review 6.  Leucine-rich repeat kinase 2 (LRRK2): a key player in the pathogenesis of Parkinson's disease.

Authors:  Payal N Gandhi; Shu G Chen; Amy L Wilson-Delfosse
Journal:  J Neurosci Res       Date:  2009-05-01       Impact factor: 4.164

7.  Leucine-rich repeat kinase 2 binds to neuronal vesicles through protein interactions mediated by its C-terminal WD40 domain.

Authors:  Giovanni Piccoli; Franco Onofri; Maria Daniela Cirnaru; Christoph J O Kaiser; Pravinkumar Jagtap; Andreas Kastenmüller; Francesca Pischedda; Antonella Marte; Felix von Zweydorf; Andreas Vogt; Florian Giesert; Lifeng Pan; Flavia Antonucci; Christina Kiel; Mingjie Zhang; Sevil Weinkauf; Michael Sattler; Carlo Sala; Michela Matteoli; Marius Ueffing; Christian Johannes Gloeckner
Journal:  Mol Cell Biol       Date:  2014-03-31       Impact factor: 4.272

8.  Parkinson's disease: leucine-rich repeat kinase 2 and autophagy, intimate enemies.

Authors:  José M Bravo-San Pedro; Rubén Gómez-Sánchez; Elisa Pizarro-Estrella; Mireia Niso-Santano; Rosa A González-Polo; José M Fuentes Rodríguez
Journal:  Parkinsons Dis       Date:  2012-08-30

9.  LRRK2 in Parkinson's disease and dementia with Lewy bodies.

Authors:  Xiongwei Zhu; Asim Babar; Sandra L Siedlak; Qiwei Yang; Genta Ito; Takeshi Iwatsubo; Mark A Smith; George Perry; Shu G Chen
Journal:  Mol Neurodegener       Date:  2006-11-30       Impact factor: 14.195

Review 10.  Epigenetic Regulation of Neuroinflammation in Parkinson's Disease.

Authors:  Madiha Rasheed; Junhan Liang; Chaolei Wang; Yulin Deng; Zixuan Chen
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.